Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-327,099
Closed -$9.04M 5135
2015
Q4
$9.04M Buy
327,099
+72,926
+29% +$2.02M 0.06% 298
2015
Q3
$6.56M Buy
+254,173
New +$6.56M 0.04% 369
2015
Q1
Sell
-548,413
Closed -$12.9M 3823
2014
Q4
$12.9M Buy
548,413
+337,897
+161% +$7.93M 0.1% 156
2014
Q3
$4.79M Buy
+210,516
New +$4.79M 0.05% 292
2014
Q2
Sell
-190,601
Closed -$4.02M 3617
2014
Q1
$4.02M Buy
+190,601
New +$4.02M 0.04% 299
2013
Q3
Sell
-76,448
Closed -$1.52M 3627
2013
Q2
$1.52M Buy
+76,448
New +$1.52M 0.03% 594

Other funds holding QGENF

Jane Street's QGENF Position: Q1 2016 in Review

Jane Street sold out of QIAGEN NV (QGENF) in Q1 2016, closing a stake of 327,099 shares — an estimated $9.04M sold.

Jane Street first reported a position in QGENF in Q2 2013 and held it in 6 quarters. The position peaked at $12.9M in Q4 2014. 201 funds tracked by Wall St. Rank hold QGENF as of Q1 2016.

  • Jane Street reported no remaining QIAGEN NV position as of Q1 2016 after selling out during the quarter.
  • Jane Street sold 327,099 QIAGEN NV shares in Q1 2016, an estimated $9.04M.
  • Jane Street first reported a position in QIAGEN NV in Q2 2013 and held it in 6 quarters.
  • Jane Street's QIAGEN NV position peaked at $12.9M in Q4 2014.
  • 201 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2016.

Based on Jane Street's 13F filing for Q1 2016, filed 17 May 2016.